Mechanisms activated by kidney disease and the loss of muscle mass

American Journal of Kidney Diseases

Volumn 38, Issue 6, 2001, Pages 1337-1342

  Mitch, William E ^a   Price, S Russ ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Metabolic acidosis; Muscle loss; Proteasomes; Ubiquitin; Uremia

Indexed keywords

CYTOKINE; GLUCOCORTICOID; PROTEASOME; UBIQUITIN;

CONFERENCE PAPER; HUMAN; KIDNEY DISEASE; METABOLIC ACIDOSIS; MUSCLE ATROPHY; MUSCLE MASS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 0035721631     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.29249     Document Type: Conference Paper

References (59)

1. Mechanisms of muscle wasting: The role of the ubiquitin-proteasome system
2. Perfect use of imperfection
3. Adaptation to low-protein diets in renal failure: Leucine turnover and nitrogen balance
4. Adaptive responses to very low protein diets: The first comparison of ketoacids to essential amino acids
5. Long-term adaptive responses to dietary protein restriction in chronic renal failure
6. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet
7. Branched-chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis
8. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism
9. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: The influence of metabolic acidosis
10. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia
11. Metabolic acidosis stimulates muscle protein degradation by activating the ATP-dependent pathway involving ubiquitin and proteasomes
12. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway
13. Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans
14. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans
15. The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure
16. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation
17. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure
18. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia
19. Correction of acidosis in hemodialysis decreases whole-body protein degradation
20. Correction of metabolic acidosis increases serum albumin concentration and decreases kinetically evaluated protein intake in hemodialysis patients: A prospective study
21. Correction of acidosis in CAPD decreases whole body protein degradation
22. Role of an improvement in acid-base status and nutrition in CAPD patients
23. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients
24. What are the causes and consequences of the chronic inflammatory in chronic hemodialysis patients?
25. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states
26. Cytokines: Agents provocateurs in hemodialysis
27. Elevated circulating levels of interleukin-6 in patients with chronic renal failure
28. Plasma levels of 1L-1B, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients
29. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α
30. Interleukin-8 in chronic renal failure and dialysis patients
31. Biological basis of hypoalbuminemia in ESRD
32. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
33. Increased mRNA levels for components of the lysosomal, Ca++-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients
34. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle
35. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
36. Multiple proteolytic systems, including the proteasome contribute CFTR processing
37. ENaC degradation in A6 cells by the ubiquitin-proteasome proteolytic pathway
38. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules
39. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats
40. The N-end rule: Functions, mysteries, uses
41. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle
42. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway
43. Proteolysis in cultured liver epithelial cells during oxidative stress: Role of the multicatalytic proteinase complex, proteasome
44. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome
45. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome
46. The dynamics of ubiquitin pools within cultured human lung fibroblasts
47. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription
48. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting
49. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle
50. Chronic metabolic acidosis accelerates whole body proteolysis and leucine oxidation in awake rats
51. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting
52. Interaction between glucocorticoids and acidification results in stimulation of proteolysis and mRNAs of proteins encoding the ubiquitin-proteasome pathway in BC3H-1 myocytes
53. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB
54. NF-κB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia
55. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-κB and inducible nitric-oxide synthase define a common myogenic signaling pathway
56. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the I kappa B alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A
57. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase
58. Transcription factors and muscle cachexia: Have we defined a therapeutic target?
59. Importance of the ATP-ubiquitin-proteasome pathway in degradation of soluble and myofibrillar proteins in rabbit muscle extracts